Laboratorios Farmaceuticos Rovi (ES:ROVI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Laboratorios Farmaceuticos Rovi reports on its third-quarter 2024 treasury stock operations under a liquidity contract with Bestinver SV, S.A., detailing trades involving over 231,000 shares purchased at an average price of 80.01 euros and over 235,000 shares sold at an average of 79.88 euros, resulting in a final securities account balance of 6,000 shares and a cash account balance of 523,209.85 euros.
For further insights into ES:ROVI stock, check out TipRanks’ Stock Analysis page.